Raytec Biotechnology to build regenerative medicine base in Chengdu Medical City

Raytec Biotechnology signed an agreement to build a regenerative medicine R&D and production base in Chengdu Medical City, Wenjiang District, including 6 production lines for medical restorative devices. The project is part of a 16-project signing event with total investment of approximately 12.4 billion yuan.

“The company will build a research and production base for regenerative medicine in Chengdu Medical City, including 6 production lines for medical restorative medical devices in fields such as ophthalmology, dentistry, and orthopedics.”en.raytecbio.com

• 1 source
• en.raytecbio.comRaytec Biotechnology Chengdu Medical City Project Signed-Guangzhou Raytec Biotechnology Co., LtdSep 21, 2020

Summarized from public sources; check the original articles before acting on it.